https://orcid.org/0000-0003-2312-8886
Figures
Abstract
Background
This study aimed to estimate, using an HIV Recent Infection Testing Algorithm (RITA), the HIV incidence and its associated factors among female sex workers (FSW) in Côte d’Ivoire.
Methods
A cross-sectional study was conducted in 2016–2017 in Abidjan and San Pedro’s region among FSW aged ≥ 18 years. In addition, a sociodemographic questionnaire, HIV screening was carried out by two rapid tests. In the event of a positive result, a dried blood spot sample was taken to determine, using a RITA adapted to the Ivorian context, if it was a recent HIV infection.
Results
A total of 1000 FSW were surveyed with a median age of 25 years (interquartile range: 21–29 years). 39 (3.9%) tested positive for HIV. The incidence of HIV was estimated to be 2.3 per 100 person-years, with higher incidence rates among those 24 years old or less (3.0% vs. 1.9%), non-Ivorian FSW (3.2% vs. 1.9%) and those with the lowest education level (4.6% in FSW who never went to school vs. 2.6%). The incidence seemed to be associated with the sex work practice conditions: higher incidence among FSW whose usual price was less than 3.50$ (4.3% vs.1.0%), FSW who had a larger number of clients on the last day of work (6.1% in those with 7 clients or more vs. 1.8%), FSW who reported not always using condoms with their clients (8.5% vs. 1.5%) and FSW who reported agreeing to sex without a condom in exchange for a large sum of money (10.1% vs. 1.2%).
Citation: Nouaman MN, Becquet V, Plazy M, Coffie PA, Zébago C, Montoyo A, et al. (2022) Incidence of HIV infection and associated factors among female sex workers in Côte d’Ivoire, results of the ANRS 12361 PrEP-CI study using recent infection assays. PLoS ONE 17(11): e0271988. https://doi.org/10.1371/journal.pone.0271988
Editor: Hamid Sharifi, HIV/STI Surveillance Research Center and WHO Collaborating Center for HIV Surveillance, Institute for Future Studies in Health, Kerman University of Medical Sciences, ISLAMIC REPUBLIC OF IRAN
Received: January 31, 2022; Accepted: July 11, 2022; Published: November 17, 2022
Copyright: © 2022 Nouaman et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: For ethical reasons, the full survey dataset is available only upon reasonable request at https://zenodo.org/record/5948841. An analytical dataset containing only the variables required to replicate the analysis, as well as the corresponding R script, are available in Supplementary material.
Funding: The PrEP-CI ANRS 12361 was funded by the Bill and Melinda Gates Foundation (Investment ID: OPP1106343) and the French National Agency for AIDS and Viral Hepatitis Research (ANRS). https://www.gatesfoundation.org/ The Bill & Melinda Gates Foundation aims to reduce inequities in health by developing new tools and strategies to reduce the burden of infectious disease.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Antiretroviral therapy (ART) decreases HIV-related morbidity and mortality as well as infectiousness, resulting in a significant reduction in the risk of HIV transmission from a treated infected person to an uninfected sexual partner [1, 2]. However, while HIV care and treatment programmes have provided access to ART for an estimated 26 million people as of 2020 worldwide, ART coverage is still far from optimal, especially in most resource-limited countries, where the HIV incidence remains relatively high. In particular, Sub-Saharan Africa is disproportionately affected by the HIV epidemic and accounts for almost 70% of HIV infections worldwide. Although new infections have been reduced by 52% since the peak in 1997, 1.7 million people had been newly infected with HIV by the end of 2019 in this region [3, 4].
Key populations and their sexual partners are at particularly high risk of HIV; in 2020, they accounted for 65% of new HIV infections worldwide. Men who have sex with men (MSM) and female sex workers (FSW) are, 25 and 26 times more likely to be infected with HIV respectively, than the general population [3]. Although the high prevalence suggests a high incidence, incidence surveys remain necessary to better understand the dynamics of the epidemic among key populations. While some data are available for MSM [5, 6], few recent incidence surveys have been conducted among FSW [7].
Moreover, HIV incidence is likely to be heterogeneous among subgroups of FSW, depending on local context, type of sex work and whether or not they attend community clinics offering various services, including HIV testing, condom distribution and prevention programmes targeting risky behaviour [8]. With the implementation of large-scale combination prevention strategies, accurate tools to monitor where and among whom new HIV infections are occurring are essential to assess the impact of these strategies and improve the effectiveness of targeted prevention programs [9–13]. In particular, new prevention tools such as pre-exposure prophylaxis are recommended by the World Health Organization (WHO) for only populations with a substantial risk of infection [14].
Therefore, it is crucial to assess the incidence of HIV infections among FSW. There are several approaches to measure the occurrence of new HIV infections in a population. The gold standard is a prospective cohorts study that analyses HIV seroconversions in uninfected individuals. However, such cohorts studies are very costly and complex to conduct. This is why the most common approach in developing countries has been inference, considering trends in HIV prevalence and assumptions about mortality and the impact of ART coverage on survival [15–18]. Recently, several laboratory approaches have been developed to distinguish newly acquired HIV infections from long-term HIV infections in cross-sectional surveys [19–21]. These incident HIV detection approaches are based on the principle that the immunological response to HIV infection evolves over several months after infection, allowing the identification of immunological biomarkers of early HIV disease that can serve as indicators of recent infection [22]. The assay-based approach involves the use of one or more serological laboratory tests that is able to classify HIV infection according to whether the infection was acquired in the recent past. Classification using one or more assays of this kind represents an HIV Recent Infection Testing Algorithm (RITA). If accurate, incidence testing can be a rapid and cost-effective approach to obtaining reliable and up-to date information about the dynamics of HIV transmission for more effective planning [23].
An HIV RITA has been developed and adapted to the Ivorian context [24]. The present paper used this HIV RITA to estimate the HIV incidence and its associated factors among FSW in two regions of Côte d’Ivoire: Abidjan and San Pedro.
Methods
Study setting
The ANRS 12361 PrEP-CI cross-sectional study was designed and implemented by two Ivorian community-based organisations between September 2016 and March 2017 [25]. Aprosam works within the city of San Pedro and its surrounding areas, particularly in villages associated with farming businesses (coffee and cocoa production). Espace Confiance operates in several districts of Abidjan, the economic capital of Côte d’Ivoire (Koumassi, Marcory, Treichville, Zone 4 and Port-Bouët including its beaches). These nongovernmental organisations (NGOs) provide HIV prevention and testing services directly at prostitution sites (outreach activities) and provide HIV and sexual health care services for FSW through community clinics. Recruitment of participants for this study was made possible by the Aprosam and Espace Confiance organisations’ networks of peer educators and their access to the target population.
Study population
The study’s purpose was not to represent all FSW in Côte d’Ivoire but rather to represent FSW who could be reached by the two partner organisations and who would potentially benefit from PrEP in a future programme. FSW are identified by the peer educator and they work at sites that are usually visited by them for HIV prevention/screening. Almost all of the FSW work sites were visited by the peer educator. The FSWs were recruited both in prostitution sites (brothel, hotel, bar/maquis, street, beach) and in the fixed clinics dedicated to sex workers of both NGOs.
The survey was conducted among FSW aged 18 years and older, who had never been tested for HIV or who had previously tested negative for HIV, and who worked at a sex work site at the time of the survey, in the areas targeted by the two community-based NGOs.
Sociodemographic and behavioural questionnaire
After obtaining informed written consent, a standardised questionnaire was administered by peer educators. The questionnaire collected sociodemographic data (date of birth, nationality, place of recruitment, level of education), as well as sexual practices and behaviours (such as the duration of sex work, the age at which sex work began, the place of meeting and activity with clients, whether sex work was carried out regularly, the use of condoms during sex work, the price of the pass (the price of a single sexual encounter with a client), the number of clients, the number of condoms used on the last day of activity and the number of sexual intercourse encounters for which a condom was not used during the last seven days).
HIV screening and laboratory analysis
HIV screening was carried out by two rapid tests (Determine®, Alere and Vikia®, bioMérieux), for all surveyed FSWs, at the sex work sites. In the event of a positive result, HIV infection was confirmed by a rapid test (stat-pack®). Then, a dried blood spot (DBS) sample was taken and transported to the laboratory of the University Hospital of Tours, France, to determine the window of infection and false positive rate using a recent infection test adapted to the Ivorian context [24] and performed directly on plasma. This recent infection test made it possible to classify HIV infections into two groups: HIV infections contracted less than 6 months prior and those contracted more than 6 months prior [24]. This recent infection test developed by Barin et al. is the Less-sensitive enzyme Immunodominant assay recent infection (EIA-RI/IDE-V3). This assay uses the enzyme immunoassay technique in a 96-well plate, based on the measurement of absorbances (OD) in one well sensitised with an equimolar peptide mixture TM (cons+D), corresponding to the immunodominant epitope of gp41 (consensus sequence envi—1 group M and consensus sequence env—1 subtype D), and in another well, sensitised with a V3 peptide solution (AE), corresponding to an equimolar mixture of the consensus sequences of the V3 region of gp120 of the HIV subtypes A, B, C, D and CRF01_AE. This test is an in-house test, applicable in the HIV-NRC virology laboratory, serology sector. The test can be performed on serum or plasma, as well as serum, plasma or whole blood on blotting paper or DBS. The test uses a mathematical formula that combines the quantitative responses to gp41 antigens in each region to distinguish between recent and established infection [24].
This in-house test has been the subject of preliminary studies using sequential serum samples from HIV-infected Ivorian patients with known dates of infection (the PRECO-CI ANRS 12277 and PRIMO-CI ANRS 1220 projects) and samples from patients at different stages of the disease (the Temprano ANRS 12136 and Trivacan ANRS 1269 trials); which allowed to distinguish a recent infection (≤180 days) from an established infection (>180 days) with a window of infection (0.3 years) and false positive rate (13‰) for the Ivorian population studied.
During the study, FSW diagnosed with HIV infection were referred to community clinics by peer educators for ART.
Description of the surveyed population
Sociodemographic characteristics and sexual practices and behaviours of the surveyed participants were described according to the study setting (San Pedro or Abidjan). Since the sample was not a random sample but rather a convenience sample of women reached by the two organisations, statistical tests such as Pearson’s χ2 test or Fisher’s exact test could not be formally used to compare differences between the populations from the two study settings. We excluded any missing data from the percentage calculations. All analyses were performed with R version R-4.2.1 software.
Assessment of HIV incidence
For a given population and HIV subtype, a RITA has a mean RITA duration ω, defined as the mean duration for which newly infected individuals in the population have had a recently acquired infection. A RITA also has a false recent rate (FRR), noted as ε, which is the proportion of non recent HIV infections in the population that are misclassified by the RITA as recent.
A RITA is used to estimate HIV infection by first classifying cases of HIV infection in the population as recently acquired or not, and then applying a mathematical formula to the resulting counts of recently acquired infections. The annual incidence rate Ir, is estimated using the following formula:
where N is the number of HIV-negative persons in the survey, P the number of HIV-positive persons, R is the number of persons classified as positive by the RITA, ω is the mean RITA duration in years and ε is the FRR of the RITA [26]. Sweeting et al., in 2010 describe this mathematical approach in more detail [27].
Regarding the RITA used in this study [24], the mean RITA duration (ω) was 0.3 years and the FRR of the RITA (ε) was 0.013.
Factors associated with HIV incidence
HIV incidence rate and their CIs were computed for the different subgroups. Unfortunately, no comparison test or multivariate analysis is currently available for RITA data.
Ethical aspects
All FSW were informed of the risks and benefits of participating in this study before inclusion. All FSW provided written informed consent. The National Ethics Committee for Life Sciences and Health of Côte d’Ivoire approved the research protocol (N/Ref: 057/MSHP/CNER-kp of 28 June 2016).
For ethical reasons, the full survey dataset is available only upon reasonable request at https://zenodo.org/record/5948841. An analytical dataset containing only the variables required to replicate the analysis, as well as the corresponding R script, are available in S1 Data.
Results
Sociodemographic and behavioural characteristics
A total of 1000 FSW, including 400 in San Pedro and 600 in Abidjan, were surveyed. The main characteristics of the surveyed population are presented in Table 1. The median age was 25 years (interquartile range: 21–29 years). The FSW surveyed in San Pedro had a lower education level than the FSW surveyed in Abidjan. The FSW in Abidjan engaged in more sex work activity than those in San Pedro. There are differences in socio-demographic characteristics between the two cities. Indeed, Abidjan is the economic capital of the country, in full expansion compared to San Pedro where the level of poverty, literacy or education is lower. San Pedro was in the recent past the largest slum in West Africa and most of the FSWs sites are within the perimeters of this slum.
Incidence of HIV infection
Among the surveyed FSW (those never tested or with a previous negative test result), 39 (3.9%) tested positive for HIV (6.3% in San Pedro and 2.3% in Abidjan) during the survey. Of these, seven FSW were classified as being recently infected according to the RITA (average duration of infection 113 days or 0.3 years).
The incidence of HIV was estimated to be 2.3 per 100 person-years overall (Table 2), with 3.3% in San Pedro and 1.6% in Abidjan.
Associated factors
Some trends emerged from the results presented in Table 2.
There were variations according to the sociodemographic characteristics of the participants, with higher incidence rates among the youngest age group (3.0% in FSW 24 years old or less vs. 1.9% in FSW 25 years old or more), non-Ivorian FSW (3.2% in non-Ivorian FSW vs. 1.9% in Ivoirian FSW) and the group with the lowest education level (4.6% in FSW who never went to school vs. 2.6% in those with a primary education level and 0.8% in those with a secondary or university education level).
The incidence of HIV also seemed to be associated with the sex work practice conditions. Indeed, FSW who charged a lower price for sexual intercourse had a higher HIV exposure rate (4.3% in FSW whose usual price was less than 3.5$ vs. 1.0% in FSW whose usual price was more than 3.5$). In addition, FSW working in brothels (4.0%), in the streets (5.4%), and in hotels (4.2%) were more likely to be recently infected than those working in bars or “maquis” (0.8%). The incidence was higher among FSW who had a larger number of clients on the last day of work (6.1% in those with 7 clients or more vs. 1.8% in those with 2–6 clients) and who worked in more than one city (3.7% vs. 1.8%). The incidence did not seem to differ according to tenure in the sex industry (2.7% in FSW who performed sex work for 3 years or more vs. 2.0% in FSW who performed sex work for 3 years or less).
A higher incidence was observed among FSW who reported not always using condoms when engaging with their clients (8.5% vs. 1.5%); who reported agreeing to sex without a condom in exchange for a large sum of money (10.1% vs. 1.2); who reported contracting a sexually transmitted infection (STI) in the last 12 months (2.6% vs. 1.9%); and who had consulted a health professional more than one year previously (4.1% vs. 1.4%).
Discussion
Our results confirm that FSW remain at high risk of exposure to HIV population in Côte d’Ivoire, with an estimated overall incidence of 2.3% (1.6% in Abidjan and 3.2% in the San Pedro region). In Côte d’Ivoire, the HIV incidence among women in the general population aged 15–64 years was estimated to be 0.03%. Specifically, it was 0.04% among women aged 15–24 years and 0.05% among those aged 25–34 years, according to the Côte d’Ivoire Population-Based HIV Impact Assessments (CIPHIA) 2017–2018 survey [28].
Our results in FSW in Côte d’Ivoire are higher than those estimated in China by Wang et al. in 2012 and in Cotonou, Benin by Diabaté et al. in 2018, who reported rates of 1.4% and 1.4%, respectively [29, 30]. On the other hand, our result was lower than 3.5% estimated by Braunstein et al. in 2011 among FSW in Rwanda [31].
Our results are consistent with well-documented risk factors associated with HIV in previous studies [29, 31, 32]. The HIV incidence was higher among those who reported having contracted an STI in the past 12 months, those who reported not always using a condom when engaging in sex work, and those who admitted to agreeing to sex without a condom in exchange for a large sum of money than among their counterparts. This high incidence of HIV infection further evidences this among FSWs in San Pedro compared to those practising in Abidjan. In fact, they charged a lower pass price with a higher number of customers. They also had a lower rate of condom use and were more likely to accept sex without condoms in exchange for a large sum of money, and they reported more STIs than those in Abidjan. All these factors favour exposure to HIV infection.
Our results also highlight that the working conditions of FSW effect the risk of HIV exposure and acquisition. Women working in brothels, hotels or on the street had higher exposure rates than those working in bars and “maquis”. It should be noted that sex work associated with bars/“maquis” are usually occasional; therefore, these FSW generally have fewer clients. A large number of clients on the last day of work was also associated with HIV acquisition. Thus, a larger number of clients increases the risk of HIV infection [29, 32].
Generally, a link between precariousness and HIV acquisition was demonstrated in our results. We observed higher incidences among less-educated FSW, younger FSM, FSW who charged a lower price for sex, FSW of foreign nationality (most often with greater social and administrative insecurity), and FSW who practised sex work in multiple cities than among their counterparts. Similarly, those who are located farther from health services have a higher risk, as the incidence was higher among those who reported not having consulted a health professional in the twelve months preceding the survey. These results corroborate the work of Szwarcwald et al. in 2018 and of Muldoon et al. in 2015 [33, 34].
We hypothesised before the survey that those who had recently entered the sex work market would be at higher risk because they have less knowledge about prevention and less capacity to negotiate condom use, but we did not observe any differences in exposure data according to the length of time they had been practising sex work. On the one hand, foreign FSW who are new to the country are usually supervised and educated by site managers about the need for systematic condom use. On the other hand, analysis of the questionnaires and qualitative interviews, which were conducted as part of the same survey and previously published [25], highlighted that despite a high rate of condom use and strong negotiation skills, FSW remain have a high HIV and other STIs exposure rate, as some sexual intercourses events do not involve the use of condoms. FSW’ responses to the question assessing condom use might refer to ‘typical use’ as opposed to specific circumstances [25]. Also the difference between reported STI cases and the proportion of condom use could be the effect of temporality. Indeed, STIs were reported in the last 12 months while responses on condom use during sex were related to current use, in the week or month before the survey. Also, FSW have difficulty negotiating condom use with their boyfriends or husbands, even when they do not know their HIV status and engage in sex with multiple sexual partners. They also willingly accept condomless sex with some regular clients whom they feel they can trust or when they are in high need of money.
Our study is one of the first to estimate the incidence of HIV in FSW in Côte d’Ivoire using tests to detect recent infection. Incidence data from at-risk populations are key in designing better programmes and interventions to limit new infections. Recent infection surveillance is a powerful tool with which Cote d’Ivoire’s national HIV/AIDS program may identify geographic areas and demographic groups within which HIV transmission is ongoing. More broadly, similar explorations would lend important insight into transmission dynamics in a high-stigma environment. Another strength of this study is the recruitment, through peer educators, of FSW with diverse profiles from different locations.
Yet, we have to acknowledge some limitations. First, as RITA is a biological assay, classification of infections as recent or not does not rely on self-reported information. Some people with long-standing HIV infection and on treatement may be misclassified as newly infected. However, these false recent cases are taken into account, as a false recent rate is applied when estimating incidence. Secondly, our data suffer from a lack of power due to a relative sample size with a few number of FSW recently HIV-infected. In addition, the comparison between San Pedro and Abidjan could not been done with statistical tests because the sample was not a random sample but rather a convenience sample. Also, our data came from a convenience sample. It was not appropriate to present the confidence intervals. We were not able to perform a multivariate analysis. Some of the observed associations may result from interactions between several variables. For example, more foreign FSW than Ivorian FSW work in brothels, resulting in foreign FSW having larger numbers of clients.
Conclusion
Although community-based prevention programmes for sex workers have led to the empowerment of FSW and a high rate of male condom use in general, they are not sufficient on their own to completely eliminate the risks of HIV acquisition. This study confirms that FSW, even those who have engaged in sex work for several years, remain highly exposed to HIV infection. Exposure to HIV is also clearly associated with certain sex-work factors and the material conditions of sex work.
Efforts in the fight against HIV infection must be intensified to reduce new infections among FSW. There is a need for appropriate people-centred prevention programmes that include new prevention tools, such as pre-exposure prophylaxis, and take into account the living and working conditions of FSW.
Acknowledgments
We would like to thank all participants as well as Aprosam’s and Espace Confiance’s peer educators and the ANRS 12361 PrEP-CI study group: Aboubakar Sangaré (Aprosam, San Pedro, Côte d’Ivoire), Anglaret Xavier (PAC-CI, Abidjan, Côte d’Ivoire / Inserm, Bordeaux, France), Anoma Camille (Espace Confiance, Abidjan, Côte d’Ivoire), Barin Francis (Université François Rabelais, Tours, France), Bazin Brigitte (ANRS, Paris, France), Becquet Valentine (Ceped/IRD, Paris, France), Dabis François (ISPED/Inserm, Bordeaux, France), Danel Christine (PAC-CI, Abidjan, Côte d’Ivoire / Inserm, Bordeaux, France), Eholie Serge (PAC-CI, Abidjan, Côte d’Ivoire), Ekouevi Didier (PAC-CI, Abidjan, Côte d’Ivoire), Fonsart Julien (Hôpital SaintLouis, Paris, France), Gbosi Kate (Aprosam, San Pedro, Côte d’Ivoire), Kwamé Abo (Programme National de Lutte contre le Sida, Côte d’Ivoire), Larmarange Joseph (Ceped/IRD, Paris, France), Masumbuko Jean-Marie (PAC-CI, Abidjan, Côte d’Ivoire), Méda Nicolas (Centre Muraz, Bobo-Dioulasso, Burkina Faso), Moh Raoul (PAC-CI, Abidjan, Côte d’Ivoire), Molina Jean-Michel (Hôpital Saint-Louis, Paris, France), N’dri-Yoman Thérèse (PAC-CI, Abidjan, Côte d’Ivoire), Nouaman Marcellin (PAC-CI, Abidjan, Côte d’Ivoire), Plazy Mélanie (ISPED / Inserm, Bordeaux, France), Soh Kouamé (Aprosam, San Pedro, Côte d’Ivoire), Tanoe Solange (Espace Confiance, Abidjan, Côte d’Ivoire), Yeo Roselyne (Espace Confiance, Abidjan, Côte d’Ivoire).
References
- 1. Eshleman SH, Hudelson SE, Redd AD, Swanstrom R, Ou S-S, Zhang XC, et al. Treatment as Prevention: Characterization of partner infections in the HIV Prevention Trials Network 052 trial. J Acquir Immune Defic Syndr 1999 2017; 74:112–116. pmid:27532476
- 2. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med 2016; 375:830–839. pmid:27424812
- 3.
Global HIV & AIDS statistics—Fact sheet. https://www.unaids.org/en/resources/fact-sheet (accessed 2 Nov2021).
- 4.
AIDS by the numbers 2015. https://www.unaids.org/sites/default/files/media_asset/AIDS_by_the_numbers_2015_en.pdf.
- 5. Kimani M, van der Elst EM, Chiro O, Oduor C, Wahome E, Kazungu W, et al. PrEP interest and HIV‐1 incidence among MSM and transgender women in coastal Kenya. J Int AIDS Soc 2019; 22:e25323. pmid:31194291
- 6. Lane T, Osmand T, Marr A, Struthers H, McIntyre JA, Shade SB. Brief Report: High HIV Incidence in a South African Community of Men Who Have Sex With Men: Results From the Mpumalanga Men’s Study, 2012–2015. J Acquir Immune Defic Syndr 1999 2016; 73:609–611.
- 7. Djomand G, Quaye S, Sullivan PS. HIV epidemic among key populations in west Africa. Curr Opin HIV AIDS 2014; 9:506–513. pmid:25010898
- 8. Nagot N, Ouangré A, Ouedraogo A, Cartoux M, Huygens P, Defer MC, et al. Spectrum of Commercial Sex Activity in Burkina Faso: Classification Model and Risk of Exposure to HIV. JAIDS J Acquir Immune Defic Syndr 2002; 29:517–521. pmid:11981369
- 9. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005; 2:e298. pmid:16231970
- 10. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493–505. pmid:21767103
- 11. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet Lond Engl 2007; 369:643–656. pmid:17321310
- 12. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet Lond Engl 2007; 369:657–666. pmid:17321311
- 13. Hirnschall G, Harries AD, Easterbrook PJ, Doherty MC, Ball A. The next generation of the World Health Organization’s global antiretroviral guidance. J Int AIDS Soc 2013; 16:18757. pmid:23819908
- 14.
Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. Geneva: World Health Organization; 2015. http://www.ncbi.nlm.nih.gov/books/NBK327115/ (accessed 19 Dec2021).
- 15. Gouws E, White PJ, Stover J, Brown T. Short term estimates of adult HIV incidence by mode of transmission: Kenya and Thailand as examples. Sex Transm Infect 2006; 82 Suppl 3:iii51–55. pmid:16735294
- 16. Hallett TB, Zaba B, Todd J, Lopman B, Mwita W, Biraro S, et al. Estimating incidence from prevalence in generalised HIV epidemics: methods and validation. PLoS Med 2008; 5:e80. pmid:18590346
- 17. Kim AA, Hallett T, Stover J, Gouws E, Musinguzi J, Mureithi PK, et al. Estimating HIV incidence among adults in Kenya and Uganda: a systematic comparison of multiple methods. PloS One 2011; 6:e17535. pmid:21408182
- 18. Stover J, Walker N, Grassly NC, Marston M. Projecting the demographic impact of AIDS and the number of people in need of treatment: updates to the Spectrum projection package. Sex Transm Infect 2006; 82 Suppl 3:iii45–50.
- 19. Le Vu S, Pillonel J, Semaille C, Bernillon P, Le Strat Y, Meyer L, et al. Principles and uses of HIV incidence estimation from recent infection testing—a review. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull 2008; 13:18969. pmid:18775292
- 20. Murphy G, Parry JV. Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull 2008; 13:18966. pmid:18775293
- 21. Mastro TD, Kim AA, Hallett T, Rehle T, Welte A, Laeyendecker O, et al. Estimating HIV Incidence in Populations Using Tests for Recent Infection: Issues, Challenges and the Way Forward. J HIV AIDS Surveill Epidemiol 2010; 2:1–14. pmid:21743821
- 22. Kim AA, Parekh BS, Umuro M, Galgalo T, Bunnell R, Makokha E, et al. Identifying Risk Factors for Recent HIV Infection in Kenya Using a Recent Infection Testing Algorithm: Results from a Nationally Representative Population-Based Survey. PLoS ONE 2016; 11. pmid:27195800
- 23. Incidence Assay Critical Path Working Group. More and better information to tackle HIV epidemics: towards improved HIV incidence assays. PLoS Med 2011; 8:e1001045. pmid:21731474
- 24. Barin F, Meyer L, Lancar R, Deveau C, Gharib M, Laporte A, et al. Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots. J Clin Microbiol 2005; 43:4441–4447. pmid:16145089
- 25. Becquet V, Nouaman M, Plazy M, Masumbuko J-M, Anoma C, Kouame S, et al. Sexual health needs of female sex workers in Côte d’Ivoire: a mixed-methods study to prepare the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention. BMJ Open 2020; 10:e028508. pmid:31919122
- 26.
World Health Organization, editor. When and how to use assays for recent infection to estimate HIV incidence at a population level. Geneva, Switzerland: World Health Organization; 2011.
- 27. Sweeting MJ, De Angelis D, Parry J, Suligoi B. Estimating the distribution of the window period for recent HIV infections: a comparison of statistical methods. Stat Med 2010; 29:3194–3202. pmid:21170913
- 28.
CIPHIA-Final-Report_Fr.pdf. https://phia.icap.columbia.edu/wp-content/uploads/2021/05/CIPHIA-Final-Report_Fr.pdf (accessed 30 Sep2021).
- 29. Wang H, Reilly KH, Brown K, Jin X, Xu J, Ding G, et al. HIV incidence and associated risk factors among female sex workers in a high HIV-prevalence area of China. Sex Transm Dis 2012; 39:835–841. pmid:23064531
- 30. Diabaté S, Chamberland A, Geraldo N, Tremblay C, Alary M. Gonorrhea, Chlamydia and HIV incidence among female sex workers in Cotonou, Benin: A longitudinal study. PloS One 2018; 13:e0197251. pmid:29746535
- 31. Braunstein SL, Ingabire CM, Kestelyn E, Uwizera AU, Mwamarangwe L, Ntirushwa J, et al. High human immunodeficiency virus incidence in a cohort of Rwandan female sex workers. Sex Transm Dis 2011; 38:385–394. pmid:22256340
- 32. Scorgie F, Chersich MF, Ntaganira I, Gerbase A, Lule F, Lo Y-R. Socio-Demographic Characteristics and Behavioral Risk Factors of Female Sex Workers in Sub-Saharan Africa: A Systematic Review. AIDS Behav 2012; 16:920–933. pmid:21750918
- 33. Szwarcwald CL, Damacena GN, de Souza-Júnior PRB, Guimarães MDC, da S de Almeida W, de Souza Ferreira AP, et al. Factors associated with HIV infection among female sex workers in Brazil. Medicine (Baltimore) 2018; 97:S54–S61. pmid:29912814
- 34. Muldoon KA. A systematic review of the clinical and social epidemiological research among sex workers in Uganda. BMC Public Health 2015; 15:1226. pmid:26652160